| 000 | 01260 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513104526.0 | ||
| 264 | 0 | _c19961113 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0895-7061 | ||
| 024 | 7 |
_a10.1016/0895-7061(96)00013-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEpstein, M | |
| 245 | 0 | 0 |
_aCalcium antagonists: still appropriate as first line antihypertensive agents. _h[electronic resource] |
| 260 |
_bAmerican journal of hypertension _cFeb 1996 |
||
| 300 |
_a110-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArteriosclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xadverse effects |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xdrug therapy |
| 650 | 0 | 4 |
_aSympathetic Nervous System _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 773 | 0 |
_tAmerican journal of hypertension _gvol. 9 _gno. 2 _gp. 110-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0895-7061(96)00013-1 _zAvailable from publisher's website |
| 999 |
_c8916687 _d8916687 |
||